TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/18/2023
Back to search
Official data from USPTO
CDS CLINICAL DIAGNOSTIC SOLUTIONS, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
04/18/2023
Trademark type
Combined
Nice classes
1
Filing date
03/08/2011
Registration date
08/07/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/15/2021
Last transaction
10/15/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
04/22/1999
First use in commerce
07/13/1999
Drawing code
3
Owner type
03
Owner location
Plantation, FL
Examiner
YARD, JOHN S
Law office
M60
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the letter "C" and the letter "D" combined to form the letter "S" with three small triangles all superimposed on two large triangles, all to the left of the words "CLINICAL DIAGNOSTIC SOLUTIONS, INC."
Holders and representatives
Holders
Clinical Diagnostic Solutions, Inc.
Representatives
Ronald N. Rosenwasser FRIEDMAN ROSENWASSER & GOLDBAUM PA
Technical classification
Nice Classes
Class 1
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
chemical reagentslytic reagentsquench reagentsenzyme reagentsrinsing reagents and cleaning reagents all for use with hematologyand/or chemical analytical automated and semi-automated study and analysis instrumentsmachines and systems used in diagnosticindustrialbiologicalcytology laboratories all for scientific use in the human clinical laboratory testing market; reagents kits comprising reagents and buffer and standard solutions used in analytical chemistry packaged in ready-to-use dispensing packages for scientific use in the human clinical laboratory testing market; fluorescent dyes for scientific usefor microscopic specimen slides and flow cytometry; Synthetic resin compounds in the form of microspheres used to incorporate other substancesmonodispersed test particles for use as standardscalibrators and carrier receptor sites employed with cytology and particle study and analysis instruments and systems used in the biologicalindustrialand/or academic fields for scientific use in the human clinical laboratory testing market; calibrating and quality control fluid for blood analyzerswhole blood hematology reference control solutions for calibration in electronic particle laboratory analysis for diagnosticscientific use in the human clinical testing laboratory testing market; Chemicalsbuffer and standard solutions used in analytical chemistry; Biochemical flow cytometry sheath fluids for scientific use; diagnostic laboratory reagents for hemoglobin testing for scientific use; reagents for use with automatic chemical analysis instruments in biologicalchemicalindustrialclinical laboratories for scientific use in the human clinical laboratory testing market
Publications
History of USPTO decisions and trademark events.
42 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/18/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/18/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/15/2021
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/15/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/15/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
09/10/2021
PUM2
OFFICE ACTION ISSUED POU2
09/03/2021
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/23/2021
PUM1
OFFICE ACTION ISSUED POU1
08/20/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/20/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
08/10/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/07/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/15/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/15/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/15/2018
E815
TEAS SECTION 8 & 15 RECEIVED
04/05/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/07/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
08/07/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/22/2012
PUBO
PUBLISHED FOR OPPOSITION
05/22/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/02/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/18/2012
ALIE
ASSIGNED TO LIE
04/17/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/27/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2012
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/27/2012
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/25/2012
GNFR
FINAL REFUSAL E-MAILED
01/25/2012
CNFR
FINAL REFUSAL WRITTEN
01/25/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/09/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/09/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/15/2011
GNRT
NON-FINAL ACTION E-MAILED
06/15/2011
CNRT
NON-FINAL ACTION WRITTEN
06/15/2011
DOCK
ASSIGNED TO EXAMINER
06/08/2011
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
03/12/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/11/2011
NWAP
NEW APPLICATION ENTERED
03/11/2011
Continuous trademark protection
Get notified about every new filing that threatens CDS CLINICAL DIAGNOSTIC SOLUTIONS, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.